Developer of a biomedical device designed to help improve female reproductive health. The company's device is a Lubricating Intravaginal Ring (IVR) that continuously delivers moisture and contains no hormones or drugs and is also long-lasting, enabling women to maintain vaginal health.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC | 04-Mar-2022 | $20K | 00.000 | Completed | Generating Revenue | |
6. Later Stage VC (Series A3) | 11-May-2021 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
5. Later Stage VC (Series A2) | 18-Dec-2019 | 00000 | 00.000 | 0000 | Completed | Generating Revenue |
4. Later Stage VC (Series A1) | 28-Aug-2017 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
3. Seed Round | 23-Nov-2015 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
2. Seed Round | 29-Nov-2012 | $540K | $1.24M | 00.000 | Completed | Generating Revenue |
1. Early Stage VC (Series A) | 18-Jul-2007 | $700K | $700K | 00.00 | Completed | Generating Revenue |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series A-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series A-1 | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
Seed II | 1,400,000 | $0.010000 | $0.6 | $0.6 | 1x | $0.6 | 9.88% | |
Seed I | 4,400,000 | $0.010000 | $0.3 | $0.3 | 1x | $0.3 | 31.04% |
Name | Representing | Role | Since |
---|---|---|---|
Duck Lee Ph.D | J3 Bioscience | Co-Chief Executive Officer, Green Cross Cell Clinical Development & Board Member | 000 0000 |
Jayne Carney Ph.D | J3 Bioscience | Executive of Market/Commercial, M&A, Licensing & Board Member | 000 0000 |
Larry Rigby | Self | Board Member & Global Market Advisor | 000 0000 |
Ron Nielsen | J3 Bioscience | Board Member | 000 0000 |
R. Tyler McCabe Ph.D | J3 Bioscience | Co-Chief Executive Officer, Development Lead & Board Member | 000 0000 |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Salt Lake Life Science Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
Tech Coast Angels | Angel Group | Minority | 000 0000 | 000000 0 |